Skip to Main Content

Paper Details

A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility.
NPJ Genom Med
4
2022
COVID, COVID-, COVID-19, GReX, IL10RB, candidate gene, coronavirus disease 2019, druggable genes, genetic loci, patient
Author NameAffiliation
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanCenter for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanCenter for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn School of Medicine at Mount Sinai
Gabriel E HoffmanIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Noam D BeckmannIcahn School of Medicine at Mount Sinai
Noam D BeckmannIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Noam D BeckmannMount Sinai Clinical Intelligence Center, Icahn School of Medicine at Mount Sinai
Sudha K IyengarCase Western Reserve University
Sudha K IyengarVA Northeast Ohio Healthcare System, Cleveland VA Medical Center
Sudha K IyengarCase Western Reserve University
Schahram AkbarianIcahn School of Medicine at Mount Sinai
Schahram AkbarianIcahn School of Medicine at Mount Sinai
Schahram AkbarianIcahn School of Medicine at Mount Sinai
Schahram AkbarianFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Themistocles L AssimesStanford University School of Medicine
Themistocles L Assimes
Eric E SchadtIcahn School of Medicine at Mount Sinai
Eric E Schadt
Eric E SchadtIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Eric E SchadtIcahn School of Medicine at Mount Sinai
Eric E SchadtIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Eric E Schadt
Julie A Lynch
Julie A LynchUniversity of Utah
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradIcahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Miriam MeradTisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Benjamin R tenOeverGrossman School of Medicine, New York University
Benjamin R tenOeverGrossman School of Medicine, New York University
Benjamin R tenOeverIcahn School of Medicine at Mount Sinai
Benjamin R tenOeverVirus Engineering Center for Therapeutics and Research, Icahn School of Medicine at Mount Sinai
Benjamin R tenOeverGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Alexander W CharneyIcahn School of Medicine at Mount Sinai
Alexander W CharneyMount Sinai Clinical Intelligence Center, Icahn School of Medicine at Mount Sinai
Kristen J BrennandIcahn School of Medicine at Mount Sinai
  • 1 - 50

Datasets